Research Alliance Corporation IV (RACD) Prices $75M IPO

Research Alliance Corporation IV (NASDAQ:RACD) announced the pricing of its $75 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “RACD” on Monday, July 13, 2026.

The new SPAC plans to search for a target in the healthcare or healthcare-related industries.

Research Alliance Corporation IV is to be led by Chief Executive Officer Matthew Hammond, Ph.D., Chief Business Officer and Chief Operating Officer Henry Stusnick alongside Chief Financial Officer Fran Adams. Alan Musso and John Maslowski will serve on its Board of Directors.

Total SPAC deal count for 2026 year-to-date is now 126. This offering is expected to close on Tuesday, July 14, 2026.

Leerink Partners is acting as the sole book running manager for the proposed offering. Cooley LLP is serving as Issuer’s Counsel with Kirkland & Ellis LLP serving as Underwriter’s Counsel. CBIZ CPAs, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.